Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Cancer treatments often cause skin, nail, and hair problems.

High levels of ornithine decarboxylase can cause tumors in mouse skin.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Sun exposure and genetics increase skin cancer risk from precancerous lesions.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Heat shock proteins help basal cell carcinoma grow by responding to inflammation signals.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Hair helps prevent scalp skin cancer by supporting immune protection.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.